Browsing by Subject ovarian cancer

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 19 of 19
Issue DateTitleAuthor(s)
16-Dec-2020Biomarker CA125 Feature Engineering and Class Imbalance Learning Improves Ovarian Cancer PredictionYang, X; Khushi, M; Shaukat, K
7-Feb-2022Carbon nanotube-coated recombinant human surfactant protein D reduces cell viability in an ovarian cancer cell line, SKOV3, and modulates mTOR pathway and pro-inflammatory cytokine responseAlshaya, DS; Jalal, AS; Alburae, NA; Aljarba, NH; Murugaiah, V; Kishore, U; Al-Qahtani, AA
31-Oct-2018Differential expression of mTOR components in endometriosis and ovarian cancer: Effects of rapalogues and dual kinase inhibitors on mTORC1 and mTORC2 stoichiometryRogers‑Broadway, KR; Kumar, J; Sisu, C; Wander, G; Mazey, E; Jeyaneethi, J; Pados, G; Tsolakidis, D; Klonos, E; Grunt, T; Hall, M; Chatterjee, J; Karteris, E
1-Feb-2022Differential Expression of RAD51AP1 in Ovarian Cancer: Effects of siRNA In VitroFilipe, A; Chudasama, D; Kerslake, R; Jeyaneethi, J; Anikin, V; Kyrou, I; Randeva, H; Sisu, C; Hall, M; Karteris, E
8-Oct-2022Differential Regulation of Genes by the Glucogenic Hormone Asprosin in Ovarian CancerKerslake, R; Sisu, C; Panfilov, S; Hall, M; Khan, N; Jeyaneethi, J; Randeva, H; Kyrou, I; Karteris, E
27-Apr-2024Effect of MYC and PARP Inhibitors in Ovarian Cancer Using an In Vitro ModelMorea, A; Saravi, S; Sisu, C; Hall, M; Tosi, S; Karteris, E; Storlazzi, CT
2-Sep-2020H2A Histone Family Member X (H2AX) Is Upregulated in Ovarian Cancer and Demonstrates Utility as a Prognostic Biomarker in Terms of Overall SurvivalSaravi, S; Katsuta, E; Jeyaneethi, J; Amin, HA; Kaspar, M; Takabe, K; Pados, G; Drenos, F; Hall, M
21-Dec-2016Human C1q Induces Apoptosis in an Ovarian Cancer Cell Line via Tumor Necrosis FactorKaur, A; Sultan, SHA; Murugaiah, V; Pathan, AA; Alhamlan, F; Karteris, E; Kishore, U
5-May-2021Identification of Potential Bisphenol A (BPA) Exposure Biomarkers in Ovarian CancerZahra, A; Dong, Q; Hall, M; Jeyaneethi, J; Silva, E; Karteris, E; Sisu, C
10-May-2022Impact of environmentally relevant concentrations of Bisphenol A (BPA) on the gene expression profile in an in vitro model of the normal human ovaryZahra, A; Kerslake, R; Kyrou, I; Randeva, HS; Sisu, C; Karteris, E
12-Sep-2019Kinase inhibitors and ovarian cancerKatopodis, P; Chudasama, D; Wander, G; Sales, L; Kumar, J; Pandhal, M; Anikin, V; Chatterjee, J; Hall, M; Karteris, E
8-Dec-2022A Meta-analysis of 2D vs. 3D Ovarian Cancer Cellular ModelsKerslake, R; Belay, B; Panfilov, S; Hall, M; Kyrou, I; Randeva, HS; Hyttinen, J; Karteris, E; Sisu, C
9-Jul-2021A pancancer overview of FBN1, asprosin and its cognate receptor OR4M1 with detailed expression profiling in ovarian cancerKerslake, R; Hall, M; Vagnarelli, P; Jeyaneethi, J; Randeva, HS; Pados, G; Kyrou, I; Karteris, E
9-Feb-2012The peritoneal tumour microenvironment of high-grade serous ovarian cancerLeinster, DA; Kulbe, H; Everitt, G; Thompson, R; Perretti, M; Gavins, FNE; Cooper, D; Gould, D; Ennis, DP; Lockley, M; McNeish, IA; Nourshargh, S; Balkwill, FR
15-Sep-2021Preclinical Studies on the Effect of Rucaparib in Ovarian Cancer: Impact of Brca2 StatusSaravi, S; Alizzi, Z; Tosi, S; Hall, M; Karteris, E
1-Mar-2016The pro-social neurohormone oxytocin reverses the actions of the stress hormone cortisol in human ovarian carcinoma cells in vitroMankarious, A; Dave, F; Pados, G; Tsolakidis, D; Gidron, Y; Pang, Y; Thomas, P; Hall, M; Karteris, E
6-Jun-2024The “Road” to Malignant Transformation from Endometriosis to Endometriosis-Associated Ovarian Cancers (EAOCs): An mTOR-Centred ReviewHablase, R; Kyrou, I; Randeva, H; Karteris, E; Chatterjee, J
9-Jul-2019Surfactant Protein D as a Potential Biomarker and Therapeutic Target in Ovarian CancerKarteris, E; Kumar, J; Murugaiah, V; Sotiriadis, G; Kaur, A; Jeyaneethi, J; Sturniolo, I; Alhamlan, F; Chatterjee, J; Hall, M; Kishore, U
26-Jun-2023Transcriptional Landscape of 3D vs. 2D Ovarian Cancer Cell ModelsKerslake, R; Belay, B; Panfilov, S; Hall, M; Kyrou, I; Randeva, HS; Hyttinen, J; Karteris, E; Sisu, C